Abstract: Techniques for cooperative preemption of resources in a distributed multi-tenant resource pool are described. A query execution service manages the allocation of computing resources in a provider network by identifying computing nodes in the provider network to preempt. The service causes the computing nodes to be removed from further executing tasks as part of processing their queries in a first group of nodes in the provider network while other computing nodes in the first group continue to execute tasks as part of processing the queries. The service then adds the first computing node into a second group of nodes in the provider network to execute tasks as part of processing other queries in the provider network.

Abstract: Various embodiments of a system and method and apparatus for determining a grouping of containers, assigning a visually distinctive indicator to the group, directing application of the visually distinctive indicator to the containers of the group are disclosed. The visually distinctive indicators of containers of a group may be analyzed manually or automatically and a message may be issued for containers that are determined to not be members of the group based on the dominant visually distinctive indicators of the group. The distinctive characteristics of the visually distinctive indicators may be colors, patterns or the like.

Abstract: A pharmaceutical composition is provided. The composition is a topical oil-in-water formulation which includes a GABA agonist such as topiramate as the active ingredient.

Abstract: The subject invention provides methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising topiramate. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury.

Abstract: A pharmaceutical composition is provided. The composition is a topical oil-in-water formulation which includes a GABA agonist such as topiramate as the active ingredient.

Abstract: The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, and anti-convulsant agent, such as topiramate, is administered to an individual.

Abstract: The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, and anti-convulsant agent, such as topiramate, is administered to an individual.

Abstract: The subject invention provides methods for treating symptoms and/or conditions associated with idiopathic hyperhidrosis by using compounds that decrease the activity of serotonin 5-HT2C receptors. Compounds that can ameliorate symptoms of idiopathic hyperhidrosis and associated conditions include 5-HT2C receptor antagonists (i.e., ketanserin, ritanserin, mianserin, mesulergine, cyproheptadine, fluoxetine, mirtazapine, olanzapine, and ziprasidone) as well as 5-HT2C receptor modulators (i.e., inverse agonists, partial agonists, and allosteric modulators).

Abstract: The subject invention provides methods for the treatment of ASD and/or PTSD comprising the administration of a dose of an SSRI taken soon after a trauma (for example, less than 48 hours and before the onset of ASD.

Abstract: Many males and females experience sexual dysfunction either caused or made worse by medications, other substances, diseases, and other medical conditions. Currently, there is need for additional treatment alternatives for these patients' sexual dysfunction. The subject invention provides a novel treatment for these individuals with sexual dysfunction by inhibiting the enzyme that breaks down acetylcholine (a compound that helps modulate normal sexual function) and elevates acetylcholine levels in the body.

Abstract: The subject invention provides methods and compositions for the treatment of neurogenetic disorders, particularly DSM-IV impulse control disorders such as intermittent explosive disorder, kleptomania, pyromania, pathologic gambling, trichotillomania, and other impulse control disorders such as compulsive buying and problematic Internet use. In a preferred embodiment, the subject invention provides methods for treating or controlling symptoms associated with ADHD or PWS comprising the administration of therapeutically effective amounts of compositions containing compounds of the formulas I-V. In another embodiment, the subject invention provides for methods of promoting wound healing comprising the administration of a therapeutically effective amount of a composition comprising the compounds of formulas I-V. Compositions may administered to a wound site via a salve, ointment, or as a component of a bandage or bioadhesive applied to the site of injury.